Recent Findings from University of Georgia Provides New Insights into Influenza A Virus Subtype H3N2 (Mrna Vaccines Encoding Computationally Optimized Hemagglutinin Elicit Protective Antibodies Against Future Antigenically Drifted H1n1 and H3n2...).

A recent study conducted at the University of Georgia has found that mRNA vaccines encoding computationally optimized hemagglutinin (HA) can elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses. Traditional seasonal influenza vaccines often provide limited protection against drifted viruses, but the use of mRNA vaccines has shown promise in generating robust neutralizing antibody responses. The study suggests that combining universal influenza antigen design technology with modern vaccine delivery platforms can lead to more effective vaccines against a broader range of influenza virus isolates. This research provides valuable insights into the potential applications of mRNA vaccines for infectious diseases beyond COVID-19. [Extracted from the article]